<PubmedArticle><MedlineCitation Status="Publisher" Owner="NLM"><PMID Version="1">39352661</PMID><DateRevised><Year>2024</Year><Month>10</Month><Day>01</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1439-0973</ISSN><JournalIssue CitedMedium="Internet"><PubDate><Year>2024</Year><Month>Oct</Month><Day>01</Day></PubDate></JournalIssue><Title>Infection</Title><ISOAbbreviation>Infection</ISOAbbreviation></Journal><ArticleTitle>No substantial neurocognitive impact of COVID-19 across ages and disease severity: a multicenter biomarker study of SARS-CoV-2 positive and negative adult and pediatric patients with acute respiratory tract infections.</ArticleTitle><ELocationID EIdType="doi" ValidYN="Y">10.1007/s15010-024-02406-7</ELocationID><Abstract><AbstractText Label="BACKGROUND" NlmCategory="BACKGROUND">Compared to intensive care unit patients with SARS-CoV-2 negative acute respiratory tract infections, patients with SARS-CoV-2 are supposed to develop more frequently and more severely neurologic sequelae. Delirium and subsequent neurocognitive deficits (NCD) have implications for patients' morbidity and mortality. However, the extent of brain injury during acute COVID-19 and subsequent NCD still remain largely unexplored. Body-fluid biomarkers may offer valuable insights into the quantification of acute delirium, brain injury and may help to predict subsequent NCD following COVID-19.</AbstractText><AbstractText Label="METHODS" NlmCategory="METHODS">In a multicenter, observational case-control study, conducted across four German University Hospitals, hospitalized adult and pediatric patients with an acute COVID-19 and SARS-CoV-2 negative controls presenting with acute respiratory tract infections were included. Study procedures comprised the assessment of pre-existing neurocognitive function, daily screening for delirium, neurological examination and blood sampling. Fourteen biomarkers indicative of neuroaxonal, glial, neurovascular injury and inflammation were analyzed. Neurocognitive functions were re-evaluated after three months.</AbstractText><AbstractText Label="RESULTS" NlmCategory="RESULTS">We enrolled 118 participants (90 adults, 28 children). The incidence of delirium [85 out of 90 patients (94.4%) were assessable for delirium) was comparable between patients with COVID-19 [16 out of 61 patients (26.2%)] and SARS-CoV-2 negative controls [8 out of 24 patients (33.3%); p &gt; 0.05] across adults and children. No differences in outcomes as measured by the modified Rankin Scale, the Short-Blessed Test, the Informant Questionnaire on Cognitive Decline in the Elderly, and the pediatrics cerebral performance category scale were observed after three months. Levels of body-fluid biomarkers were generally elevated in both adult and pediatric cohorts, without significant differences between SARS-CoV-2 negative controls and COVID-19. In COVID-19 patients experiencing delirium, levels of GFAP and MMP-9 were significantly higher compared to those without delirium.</AbstractText><AbstractText Label="CONCLUSIONS" NlmCategory="CONCLUSIONS">Delirium and subsequent NCD are not more frequent in COVID-19 as compared to SARS-CoV-2 negative patients with acute respiratory tract infections. Consistently, biomarker levels of brain injury indicated no differences between COVID-19 cases and SARS-CoV-2 negative controls. Our data suggest that delirium in COVID-19 does not distinctly trigger substantial and persistent subsequent NCD compared to patients with other acute respiratory tract infections.</AbstractText><AbstractText Label="TRIAL REGISTRATION" NlmCategory="BACKGROUND">ClinicalTrials.gov: NCT04359914; date of registration 24-APR 2020.</AbstractText><CopyrightInformation>© 2024. The Author(s).</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Ehler</LastName><ForeName>Johannes</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>Department of Anesthesiology, Intensive Care Medicine and Pain Therapy, Rostock University Medical Center, 18057, Rostock, Germany. johannes.ehler@med.uni-jena.de.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Anesthesiology and Intensive Care Medicine, Jena University Hospital, 07747, Jena, Germany. johannes.ehler@med.uni-jena.de.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Klawitter</LastName><ForeName>Felix</ForeName><Initials>F</Initials><AffiliationInfo><Affiliation>Department of Anesthesiology, Intensive Care Medicine and Pain Therapy, Rostock University Medical Center, 18057, Rostock, Germany.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>von Möllendorff</LastName><ForeName>Friedrich</ForeName><Initials>F</Initials><AffiliationInfo><Affiliation>Department of Anesthesiology, Intensive Care Medicine and Pain Therapy, Rostock University Medical Center, 18057, Rostock, Germany.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Zacharias</LastName><ForeName>Maike</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Department of Anaesthesiology, LMU Hospital, LMU Munich, 81377, Munich, Germany.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Fischer</LastName><ForeName>Dagmar-Christiane</ForeName><Initials>DC</Initials><AffiliationInfo><Affiliation>Department of Pediatrics, Rostock University Medical Center, 18057, Rostock, Germany.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Danckert</LastName><ForeName>Lena</ForeName><Initials>L</Initials><AffiliationInfo><Affiliation>Department of Anesthesiology, Intensive Care Medicine and Pain Therapy, Rostock University Medical Center, 18057, Rostock, Germany.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Bajorat</LastName><ForeName>Rika</ForeName><Initials>R</Initials><AffiliationInfo><Affiliation>Department of Anesthesiology, Intensive Care Medicine and Pain Therapy, Rostock University Medical Center, 18057, Rostock, Germany.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Hackenberg</LastName><ForeName>Johanna</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>Department of Pediatrics, Rostock University Medical Center, 18057, Rostock, Germany.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Bertsche</LastName><ForeName>Astrid</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Department of Pediatrics, Rostock University Medical Center, 18057, Rostock, Germany.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Pediatrics, Division of Neuropediatrics, Greifswald University Medical Center, 17475, Greifswald, Germany.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Loebermann</LastName><ForeName>Micha</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Department of Tropical Medicine, Infectious Diseases and Nephrology, Rostock University Medical Center, 18057, Rostock, Germany.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Geerdes-Fenge</LastName><ForeName>Hilte</ForeName><Initials>H</Initials><AffiliationInfo><Affiliation>Department of Tropical Medicine, Infectious Diseases and Nephrology, Rostock University Medical Center, 18057, Rostock, Germany.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Fleischmann</LastName><ForeName>Robert</ForeName><Initials>R</Initials><AffiliationInfo><Affiliation>Department of Neurology, Greifswald University Medical Center, 17475, Greifswald, Germany.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Klinkmann</LastName><ForeName>Gerd</ForeName><Initials>G</Initials><AffiliationInfo><Affiliation>Department of Anesthesiology, Intensive Care Medicine and Pain Therapy, Rostock University Medical Center, 18057, Rostock, Germany.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Schramm</LastName><ForeName>Patrick</ForeName><Initials>P</Initials><AffiliationInfo><Affiliation>Department of Neurology, Justus Liebig University, 35385, Giessen, Germany.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Schober</LastName><ForeName>Sarah</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>Department I-General Pediatrics, Hematology and Oncology, University Children's Hospital, Tübingen, Hoppe-Seyler-Str. 1, 72076, Tübingen, Germany.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Petzold</LastName><ForeName>Axel</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Department of Molecular Neuroscience, The National Hospital for Neurology and Neurosurgery, Queen Square Institute of Neurology, Moorfields Eye Hospital, UCL, London, UK.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Departments of Neurology, Ophthalmology and Expertise-Center for Neuro-ophthalmology, Amsterdam UMC, Amsterdam, The Netherlands.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Perneczky</LastName><ForeName>Robert</ForeName><Initials>R</Initials><AffiliationInfo><Affiliation>Department of Psychiatry and Psychotherapy, LMU Hospital, LMU Munich, 80336, Munich, Germany.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>German Center for Neurodegenerative Diseases Munich (DZNE), 81377, Munich, Germany.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Munich Cluster for Systems Neurology (SyNergy), 81377, Munich, Germany.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Sheffield Institute for Translational Neuroscience (SiTrAN), University of Sheffield, Sheffield, S10 2HQ, UK.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Ageing Epidemiology (AGE) Research Unit, School of Public Health, Imperial College London, London, W6 8RP, UK.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Saller</LastName><ForeName>Thomas</ForeName><Initials>T</Initials><AffiliationInfo><Affiliation>Department of Anaesthesiology, LMU Hospital, LMU Munich, 81377, Munich, Germany.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><DataBankList CompleteYN="Y"><DataBank><DataBankName>ClinicalTrials.gov</DataBankName><AccessionNumberList><AccessionNumber>NCT04359914</AccessionNumber></AccessionNumberList></DataBank></DataBankList><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2024</Year><Month>10</Month><Day>01</Day></ArticleDate></Article><MedlineJournalInfo><Country>Germany</Country><MedlineTA>Infection</MedlineTA><NlmUniqueID>0365307</NlmUniqueID><ISSNLinking>0300-8126</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">Biomarkers (D015415)</Keyword><Keyword MajorTopicYN="N">COVID-19 (MeSH unique ID D000086382)</Keyword><Keyword MajorTopicYN="N">Critical care (D003422)</Keyword><Keyword MajorTopicYN="N">Delirium (D003693)</Keyword><Keyword MajorTopicYN="N">Neurocognitive disorders (D019965)</Keyword></KeywordList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2024</Year><Month>5</Month><Day>25</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2024</Year><Month>9</Month><Day>23</Day></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2024</Year><Month>10</Month><Day>1</Day><Hour>12</Hour><Minute>43</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2024</Year><Month>10</Month><Day>1</Day><Hour>12</Hour><Minute>43</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2024</Year><Month>10</Month><Day>1</Day><Hour>11</Hour><Minute>20</Minute></PubMedPubDate></History><PublicationStatus>aheadofprint</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">39352661</ArticleId><ArticleId IdType="doi">10.1007/s15010-024-02406-7</ArticleId><ArticleId IdType="pii">10.1007/s15010-024-02406-7</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Dimitriadis K, Meis J, Neugebauer H, Barlinn K, Neumann B, Gahn G, et al. Neurologic manifestations of COVID-19 in critically ill patients: results of the prospective multicenter registry PANDEMIC. Crit Care. 2022;26:217. https://doi.org/10.1186/s13054-022-04080-3 .</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s13054-022-04080-3</ArticleId><ArticleId IdType="pubmed">35842675</ArticleId><ArticleId IdType="pmc">9287707</ArticleId></ArticleIdList></Reference><Reference><Citation>Helms J, Kremer S, Merdji H, Schenck M, Severac F, Clere-Jehl R, et al. Delirium and Encephalopathy in severe COVID-19: a cohort analysis of ICU patients. Crit Care. 2020;24:491. https://doi.org/10.1186/s13054-020-03200-1 .</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s13054-020-03200-1</ArticleId><ArticleId IdType="pubmed">32771053</ArticleId><ArticleId IdType="pmc">7414289</ArticleId></ArticleIdList></Reference><Reference><Citation>Beretta S, Stabile A, Balducci C, DiFrancesco JC, Patruno A, Rona R, et al. COVID-19-associated immune-mediated encephalitis mimicking acute-onset Creutzfeldt-Jakob disease. Ann Clin Transl Neurol. 2021;8:2314–8. https://doi.org/10.1002/acn3.51479 .</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/acn3.51479</ArticleId><ArticleId IdType="pubmed">34825771</ArticleId><ArticleId IdType="pmc">8670319</ArticleId></ArticleIdList></Reference><Reference><Citation>Crunfli F, Carregari VC, Veras FP, Silva LS, Nogueira MH, Antunes A, et al. Morphological, cellular, and molecular basis of brain infection in COVID-19 patients. Proc Natl Acad Sci USA. 2022;119:e2200960119. https://doi.org/10.1073/pnas.2200960119 .</Citation><ArticleIdList><ArticleId IdType="doi">10.1073/pnas.2200960119</ArticleId><ArticleId IdType="pubmed">35951647</ArticleId><ArticleId IdType="pmc">9436354</ArticleId></ArticleIdList></Reference><Reference><Citation>Douaud G, Lee S, Alfaro-Almagro F, Arthofer C, Wang C, McCarthy P, et al. SARS-CoV-2 is associated with changes in brain structure in UK Biobank. medRxiv. 2022. https://doi.org/10.1101/2021.06.11.21258690 .</Citation><ArticleIdList><ArticleId IdType="doi">10.1101/2021.06.11.21258690</ArticleId><ArticleId IdType="pubmed">34189535</ArticleId><ArticleId IdType="pmc">8240690</ArticleId></ArticleIdList></Reference><Reference><Citation>Alonazi B, Farghaly AM, Mostafa MA, Al-Watban JA, Zindani SA, Altaimi F, et al. Brain MRI in SARS-CoV-2 pneumonia patients with newly developed neurological manifestations suggestive of brain involvement. Sci Rep. 2021;11:20476. https://doi.org/10.1038/s41598-021-00064-5 .</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41598-021-00064-5</ArticleId><ArticleId IdType="pubmed">34650073</ArticleId><ArticleId IdType="pmc">8516985</ArticleId></ArticleIdList></Reference><Reference><Citation>Tremblay ME, Madore C, Bordeleau M, Tian L, Verkhratsky A. Neuropathobiology of COVID-19: the role for Glia. Front Cell Neurosci. 2020;14:592214. https://doi.org/10.3389/fncel.2020.592214 .</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fncel.2020.592214</ArticleId><ArticleId IdType="pubmed">33304243</ArticleId><ArticleId IdType="pmc">7693550</ArticleId></ArticleIdList></Reference><Reference><Citation>Ollila H, Pihlaja R, Koskinen S, Tuulio-Henriksson A, Salmela V, Tiainen M, et al. Long-term cognitive functioning is impaired in ICU-treated COVID-19 patients: a comprehensive controlled neuropsychological study. Crit Care. 2022;26:223. https://doi.org/10.1186/s13054-022-04092-z .</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s13054-022-04092-z</ArticleId><ArticleId IdType="pubmed">35858899</ArticleId><ArticleId IdType="pmc">9297673</ArticleId></ArticleIdList></Reference><Reference><Citation>Avittan H, Kustovs D. Cognition and Mental Health in Pediatric patients following COVID-19. Int J Environ Res Public Health. 2023;20. https://doi.org/10.3390/ijerph20065061 .</Citation></Reference><Reference><Citation>Casey CP, Lindroth H, Mohanty R, Farahbakhsh Z, Ballweg T, Twadell S, et al. Postoperative delirium is associated with increased plasma neurofilament light. Brain. 2020;143:47–54. https://doi.org/10.1093/brain/awz354 .</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/brain/awz354</ArticleId><ArticleId IdType="pubmed">31802104</ArticleId></ArticleIdList></Reference><Reference><Citation>Ballweg T, White M, Parker M, Casey C, Bo A, Farahbakhsh Z, et al. Association between plasma tau and postoperative delirium incidence and severity: a prospective observational study. Br J Anaesth. 2021;126:458–66. https://doi.org/10.1016/j.bja.2020.08.061 .</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.bja.2020.08.061</ArticleId><ArticleId IdType="pubmed">33228978</ArticleId></ArticleIdList></Reference><Reference><Citation>Fong TG, Vasunilashorn SM, Ngo L, Libermann TA, Dillon ST, Schmitt EM, et al. Association of Plasma Neurofilament Light with postoperative delirium. Ann Neurol. 2020;88:984–94. https://doi.org/10.1002/ana.25889 .</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/ana.25889</ArticleId><ArticleId IdType="pubmed">32881052</ArticleId><ArticleId IdType="pmc">7581557</ArticleId></ArticleIdList></Reference><Reference><Citation>Petzold A, Downie P, Smith M. Critical illness brain syndrome (CIBS): an underestimated entity? Crit Care Med. 2005;33:1464. https://doi.org/10.1097/01.ccm.0000166866.47020.e5 . author reply 1464–1465.</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/01.ccm.0000166866.47020.e5</ArticleId><ArticleId IdType="pubmed">15942395</ArticleId></ArticleIdList></Reference><Reference><Citation>Ehler J, Petzold A, Sharshar T, Ely EW, Saller T. Biomarker Panel to Differentiate Brain Injury from Brain Dysfunction in patients with Sepsis-Associated Encephalopathy. Crit Care Med. 2020;48:e436–7. https://doi.org/10.1097/CCM.0000000000004266 .</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/CCM.0000000000004266</ArticleId><ArticleId IdType="pubmed">32301790</ArticleId></ArticleIdList></Reference><Reference><Citation>Ehler J, Barrett LK, Taylor V, Groves M, Scaravilli F, Wittstock M, et al. Translational evidence for two distinct patterns of neuroaxonal injury in sepsis: a longitudinal, prospective translational study. Crit Care. 2017;21:262. https://doi.org/10.1186/s13054-017-1850-7 .</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s13054-017-1850-7</ArticleId><ArticleId IdType="pubmed">29058589</ArticleId><ArticleId IdType="pmc">5653470</ArticleId></ArticleIdList></Reference><Reference><Citation>Quintard H, Leduc S, Ferrari P, Petit I, Ichai C. Early and persistent high level of PS 100beta is associated with increased poor neurological outcome in patients with SAH: is there a PS 100beta threshold for SAH prognosis? Crit Care. 2016;20:33. https://doi.org/10.1186/s13054-016-1200-1 .</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s13054-016-1200-1</ArticleId><ArticleId IdType="pubmed">26843206</ArticleId><ArticleId IdType="pmc">4738799</ArticleId></ArticleIdList></Reference><Reference><Citation>Bircak-Kuchtova B, Chung HY, Wickel J, Ehler J, Geis C. Neurofilament light chains to assess sepsis-associated encephalopathy: are we on the track toward clinical implementation? Crit Care. 2023;27:214. https://doi.org/10.1186/s13054-023-04497-4 .</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s13054-023-04497-4</ArticleId><ArticleId IdType="pubmed">37259091</ArticleId><ArticleId IdType="pmc">10230136</ArticleId></ArticleIdList></Reference><Reference><Citation>van den Boogaard M, Kox M, Quinn KL, van Achterberg T, van der Hoeven JG, Schoonhoven L, et al. Biomarkers associated with delirium in critically ill patients and their relation with long-term subjective cognitive dysfunction; indications for different pathways governing delirium in inflamed and noninflamed patients. Crit Care. 2011;15:R297. https://doi.org/10.1186/cc10598 .</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/cc10598</ArticleId><ArticleId IdType="pubmed">22206727</ArticleId><ArticleId IdType="pmc">3388649</ArticleId></ArticleIdList></Reference><Reference><Citation>Gillespie AL, Wigg C, Van Assche I, Murphy SE, Harmer CJ. Associations between Statin Use and negative affective Bias during COVID-19: an observational, longitudinal UK Study investigating Depression vulnerability. Biol Psychiatry. 2022;92:543–51. https://doi.org/10.1016/j.biopsych.2022.03.009 .</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.biopsych.2022.03.009</ArticleId><ArticleId IdType="pubmed">35606186</ArticleId><ArticleId IdType="pmc">8933284</ArticleId></ArticleIdList></Reference><Reference><Citation>Verde F, Milone I, Bulgarelli I, Peverelli S, Colombrita C, Maranzano A, et al. Serum neurofilament light chain levels in Covid-19 patients without major neurological manifestations. J Neurol. 2022;269:5691–701. https://doi.org/10.1007/s00415-022-11233-5 .</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00415-022-11233-5</ArticleId><ArticleId IdType="pubmed">35781535</ArticleId><ArticleId IdType="pmc">9252542</ArticleId></ArticleIdList></Reference><Reference><Citation>Hanson BA, Visvabharathy L, Ali ST, Kang AK, Patel TR, Clark JR, et al. Plasma biomarkers of neuropathogenesis in hospitalized patients with COVID-19 and those with Postacute Sequelae of SARS-CoV-2 infection. Neurol Neuroimmunol Neuroinflamm. 2022;9. https://doi.org/10.1212/NXI.0000000000001151 .</Citation></Reference><Reference><Citation>Savarraj J, Park ES, Colpo GD, Hinds SN, Morales D, Ahnstedt H, et al. Brain injury, endothelial injury and inflammatory markers are elevated and express sex-specific alterations after COVID-19. J Neuroinflammation. 2021;18:277. https://doi.org/10.1186/s12974-021-02323-8 .</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s12974-021-02323-8</ArticleId><ArticleId IdType="pubmed">34838058</ArticleId><ArticleId IdType="pmc">8627162</ArticleId></ArticleIdList></Reference><Reference><Citation>Sutter R, Hert L, De Marchis GM, Twerenbold R, Kappos L, Naegelin Y, et al. Serum neurofilament light chain levels in the Intensive Care Unit: comparison between severely ill patients with and without Coronavirus Disease 2019. Ann Neurol. 2021;89:610–6. https://doi.org/10.1002/ana.26004 .</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/ana.26004</ArticleId><ArticleId IdType="pubmed">33377539</ArticleId></ArticleIdList></Reference><Reference><Citation>Bonetto V, Pasetto L, Lisi I, Carbonara M, Zangari R, Ferrari E, et al. Markers of blood-brain barrier disruption increase early and persistently in COVID-19 patients with neurological manifestations. Front Immunol. 2022;13:1070379. https://doi.org/10.3389/fimmu.2022.1070379 .</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fimmu.2022.1070379</ArticleId><ArticleId IdType="pubmed">36591311</ArticleId><ArticleId IdType="pmc">9798841</ArticleId></ArticleIdList></Reference><Reference><Citation>Frontera JA, Boutajangout A, Masurkar AV, Betensky RA, Ge Y, Vedvyas A, et al. Comparison of serum neurodegenerative biomarkers among hospitalized COVID-19 patients versus non-COVID subjects with normal cognition, mild cognitive impairment, or Alzheimer’s dementia. Alzheimers Dement. 2022;18:899–910. https://doi.org/10.1002/alz.12556 .</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/alz.12556</ArticleId><ArticleId IdType="pubmed">35023610</ArticleId></ArticleIdList></Reference><Reference><Citation>Plantone D, Locci S, Bergantini L, Manco C, Cortese R, Meocci M, et al. Brain neuronal and glial damage during acute COVID-19 infection in absence of clinical neurological manifestations. J Neurol Neurosurg Psychiatry. 2022;93:1343–8. https://doi.org/10.1136/jnnp-2022-329933 .</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/jnnp-2022-329933</ArticleId><ArticleId IdType="pubmed">36137741</ArticleId></ArticleIdList></Reference><Reference><Citation>Girard TD, Self WH, Edwards KM, Grijalva CG, Zhu Y, Williams DJ, et al. Long-term cognitive impairment after hospitalization for community-acquired pneumonia: a prospective cohort study. J Gen Intern Med. 2018;33:929–35. https://doi.org/10.1007/s11606-017-4301-x .</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s11606-017-4301-x</ArticleId><ArticleId IdType="pubmed">29374359</ArticleId><ArticleId IdType="pmc">5975139</ArticleId></ArticleIdList></Reference><Reference><Citation>Chung HY, Neu C, Wickel J, Kuckertz SL, Coldewey SM. Neurofilament light chain in patients with COVID-19 and bacterial pneumonia. Ann Neurol. 2021;90:174–5. https://doi.org/10.1002/ana.26135 .</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/ana.26135</ArticleId><ArticleId IdType="pubmed">34036618</ArticleId><ArticleId IdType="pmc">8222870</ArticleId></ArticleIdList></Reference><Reference><Citation>Needham EJ, Ren AL, Digby RJ, Norton EJ, Ebrahimi S, Outtrim JG, et al. Brain injury in COVID-19 is associated with dysregulated innate and adaptive immune responses. Brain. 2022;145:4097–107. https://doi.org/10.1093/brain/awac321 .</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/brain/awac321</ArticleId><ArticleId IdType="pubmed">36065116</ArticleId><ArticleId IdType="pmc">9494359</ArticleId></ArticleIdList></Reference><Reference><Citation>Peluso MJ, Sans HM, Forman CA, Nylander AN, Ho HE, Lu S, et al. Plasma markers of neurologic Injury and inflammation in people with self-reported neurologic Postacute sequelae of SARS-CoV-2 infection. Neurol Neuroimmunol Neuroinflamm. 2022;9. https://doi.org/10.1212/NXI.0000000000200003 .</Citation></Reference><Reference><Citation>Saller T, Petzold A, Zetterberg H, Kuhle J, Chappell D, von Dossow V, et al. A case series on the value of tau and neurofilament protein levels to predict and detect delirium in cardiac surgery patients. Biomed Pap Med Fac Univ Palacky Olomouc Czech Repub. 2019;163:241–6. https://doi.org/10.5507/bp.2019.043 .</Citation><ArticleIdList><ArticleId IdType="doi">10.5507/bp.2019.043</ArticleId><ArticleId IdType="pubmed">31530945</ArticleId></ArticleIdList></Reference><Reference><Citation>Cape E, Hall RJ, van Munster BC, de Vries A, Howie SE, Pearson A, et al. Cerebrospinal fluid markers of neuroinflammation in delirium: a role for interleukin-1beta in delirium after hip fracture. J Psychosom Res. 2014;77:219–25. https://doi.org/10.1016/j.jpsychores.2014.06.014 .</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jpsychores.2014.06.014</ArticleId><ArticleId IdType="pubmed">25124807</ArticleId><ArticleId IdType="pmc">4274366</ArticleId></ArticleIdList></Reference><Reference><Citation>Liu LF, Hu Y, Liu YN, Shi DW, Liu C, Da X, et al. Reactive oxygen species contribute to delirium-like behavior by activating CypA/MMP9 signaling and inducing blood-brain barrier impairment in aged mice following anesthesia and surgery. Front Aging Neurosci. 2022;14:1021129. https://doi.org/10.3389/fnagi.2022.1021129 .</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fnagi.2022.1021129</ArticleId><ArticleId IdType="pubmed">36337710</ArticleId><ArticleId IdType="pmc">9629746</ArticleId></ArticleIdList></Reference><Reference><Citation>Mietani K, Hasegawa-Moriyama M, Yagi K, Inoue R, Ogata T, Shimojo N, et al. Elevation of serum plasminogen activator inhibitor-1 predicts postoperative delirium independent of neural damage: a sequential analysis. Sci Rep. 2022;12:17091. https://doi.org/10.1038/s41598-022-21682-7 .</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41598-022-21682-7</ArticleId><ArticleId IdType="pubmed">36224337</ArticleId><ArticleId IdType="pmc">9556513</ArticleId></ArticleIdList></Reference><Reference><Citation>Brummel NE, Hughes CG, Thompson JL, Jackson JC, Pandharipande P, McNeil JB, et al. Inflammation and coagulation during critical illness and long-term cognitive impairment and disability. Am J Respir Crit Care Med. 2021;203:699–706. https://doi.org/10.1164/rccm.201912-2449OC .</Citation><ArticleIdList><ArticleId IdType="doi">10.1164/rccm.201912-2449OC</ArticleId><ArticleId IdType="pubmed">33030981</ArticleId><ArticleId IdType="pmc">7958515</ArticleId></ArticleIdList></Reference><Reference><Citation>Theoharides TC, Kempuraj D. Role of SARS-CoV-2 Spike-Protein-Induced activation of Microglia and mast cells in the pathogenesis of Neuro-COVID. Cells. 2023;12. https://doi.org/10.3390/cells12050688 .</Citation></Reference><Reference><Citation>Misra S, Kolappa K, Prasad M, Radhakrishnan D, Thakur KT, Solomon T, et al. Frequency of neurologic manifestations in COVID-19: a systematic review and Meta-analysis. Neurology. 2021;97:e2269–81. https://doi.org/10.1212/WNL.0000000000012930 .</Citation><ArticleIdList><ArticleId IdType="doi">10.1212/WNL.0000000000012930</ArticleId><ArticleId IdType="pubmed">34635561</ArticleId><ArticleId IdType="pmc">8665434</ArticleId></ArticleIdList></Reference><Reference><Citation>Panda PK, Sharawat IK, Panda P, Natarajan V, Bhakat R, Dawman L. Neurological complications of SARS-CoV-2 infection in children: a systematic review and Meta-analysis. J Trop Pediatr. 2021;67. https://doi.org/10.1093/tropej/fmaa070 .</Citation></Reference><Reference><Citation>Geis T, Brandstetter S, Toncheva AA, Laub O, Leipold G, Wagner R, et al. Serum neurofilament light chain (sNfL) values in a large cross-sectional population of children with asymptomatic to moderate COVID-19. J Neurol. 2021;268:3969–74. https://doi.org/10.1007/s00415-021-10554-1 .</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00415-021-10554-1</ArticleId><ArticleId IdType="pubmed">33893540</ArticleId><ArticleId IdType="pmc">8064423</ArticleId></ArticleIdList></Reference><Reference><Citation>Pavan Kumar N, Venkataraman A, Varadarjan P, Nancy A, Rajamanickam A, Selladurai E, et al. Role of matrix metalloproteinases in multi-system inflammatory syndrome and acute COVID-19 in children. Front Med (Lausanne). 2022;9:1050804. https://doi.org/10.3389/fmed.2022.1050804 .</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fmed.2022.1050804</ArticleId><ArticleId IdType="pubmed">36544496</ArticleId></ArticleIdList></Reference><Reference><Citation>Bark L, Larsson IM, Wallin E, Simren J, Zetterberg H, Lipcsey M, et al. Central nervous system biomarkers GFAp and NfL associate with post-acute cognitive impairment and fatigue following critical COVID-19. Sci Rep. 2023;13:13144. https://doi.org/10.1038/s41598-023-39698-y .</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41598-023-39698-y</ArticleId><ArticleId IdType="pubmed">37573366</ArticleId><ArticleId IdType="pmc">10423244</ArticleId></ArticleIdList></Reference><Reference><Citation>Ziff OJ, Ashton NJ, Mehta PR, Brown R, Athauda D, Heaney J, et al. Amyloid processing in COVID-19-associated neurological syndromes. J Neurochem. 2022;161:146–57. https://doi.org/10.1111/jnc.15585 .</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/jnc.15585</ArticleId><ArticleId IdType="pubmed">35137414</ArticleId><ArticleId IdType="pmc">9115071</ArticleId></ArticleIdList></Reference><Reference><Citation>de Boni L, Odainic A, Gancarczyk N, Kaluza L, Strassburg CP, Kersting XAK, et al. No serological evidence for neuronal damage or reactive gliosis in neuro-COVID-19 patients with long-term persistent headache. Neurol Res Pract. 2022;4:53. https://doi.org/10.1186/s42466-022-00217-5 .</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s42466-022-00217-5</ArticleId><ArticleId IdType="pubmed">36310154</ArticleId><ArticleId IdType="pmc">9618412</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle>